Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

GlobalData, the industry analysis specialist, has released its new report, “Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Chemotherapy induced Nausea and Vomiting Therapeutics market. The report identifies the key trends shaping and driving the global Chemotherapy induced Nausea and Vomiting Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Chemotherapy induced Nausea and Vomiting Therapeutics sector.

Scope

• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Chemotherapy induced Nausea and Vomiting Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
• Analysis of the current and future competition in the seven key countries Chemotherapy induced Nausea and Vomiting Therapeutics market.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

Explore Comprehensive list of Tables & Figures available in the report
CINV Therapeutics Market Forecasts

Report Details:
Published: February 2012
No. of Pages: 81
Price: Single User License – US$3995 Corporate User License – US$11985

Reasons to buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the global Chemotherapy induced Nausea and Vomiting Therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Chemotherapy induced Nausea and Vomiting Therapeutics market in future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Major points covered in Table of Contents of this report include

1 Table of Contents 2
2 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Introduction 7
3 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Market Characterization 23
4 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Competitive Assessment 44
5 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment 53
6 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Clinical Trials Mapping 59
7 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Strategic Assessment 65
8 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Future Players 66
9 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Licensing and Partnership Deals 72
10 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Appendix 74
List of Tables

Browse all Therapeutic Market Research Reports